subperiosteal implants
Clinical and Radiographic Assessment of Milled Versus 3D-Printed Patient-Specific Subperiosteal Implants for Atrophic Mandibular Ridges: A Randomized Clinical Trial
- 10 March 2025
- Posted by: anjaform
- Category: Clinical Studies and Case Reports
Saad A. Darwish, Wael A. El-Mohandes, Bahaa El-Din Abd Rabbo
Full text link: https://pubmed.ncbi.nlm.nih.gov/40206923/
Clinical and Radiographic Assessment of Milled Versus 3D-Printed Patient-Specific Subperiosteal Implants for Atrophic Mandibular Ridges: A Randomized Clinical Trial
1. Scientific Reference
- Study title: Clinical and Radiographic Assessment of Milled Versus 3D-Printed Patient-Specific Subperiosteal Implants for Atrophic Mandibular Ridges: A Randomized Clinical Trial
- Authors: Saad A. Darwish, Wael A. El-Mohandes, Bahaa El-Din Abd Rabbo
- Journal: Cureus
- Publication year: 2025
- DOI: 10.7759/cureus.80326
2. Scientific Background
Managing patients with severely atrophic edentulous mandibles remains one of the most demanding challenges in implant dentistry. When residual bone volume is insufficient for conventional endosseous implants, clinicians often rely on advanced reconstructive procedures such as bone grafting or ridge augmentation. While effective in selected cases, these approaches may increase surgical morbidity, prolong treatment time, and may not be appropriate for every patient.
Recent advances in digital dentistry have revived interest in patient-specific subperiosteal implants (PSIs). Combining cone beam computed tomography (CBCT), computer-aided design (CAD), and computer-aided manufacturing (CAM) allows clinicians to design customized titanium frameworks that conform precisely to each patient’s anatomy. These implants can be manufactured either through subtractive milling or additive 3D printing, two technologies that have become increasingly accessible in modern implant rehabilitation.
Against this background, the present randomized clinical trial evaluates whether the manufacturing technique itself influences the clinical and radiographic performance of customized subperiosteal implants used for rehabilitation of severely atrophic mandibular ridges.
3. Study Objective
The primary objective of this randomized clinical trial was to compare the clinical and radiographic outcomes of patient-specific subperiosteal implants manufactured using either CAD/CAM milling or metal 3D printing in patients with severely atrophic mandibles.
The investigators specifically assessed implant survival, peri-implant bone stability, placement accuracy, surgical duration, and soft tissue healing to determine whether one manufacturing technique demonstrated superior clinical performance during the first year after surgery.
4. Methodology
This investigation was designed as a parallel-group randomized clinical trial with a 1:1 allocation ratio. Twenty patients presenting with severely atrophic edentulous mandibular ridges, defined by a residual bone height of less than 6 mm above the inferior alveolar nerve, were randomly assigned to receive customized titanium subperiosteal implants produced either by CAD/CAM milling or additive metal 3D printing.
Each patient underwent a fully digital workflow that included CBCT imaging, virtual implant planning, computer-assisted implant design, and fabrication of patient-specific surgical guides. All implants were manufactured from Grade 4 titanium and fixed to the mandibular cortical bone using multiple mini-screws.
Patients were followed for 12 months. Primary outcome measures included implant survival, bone resorption, and implant placement accuracy assessed through postoperative CBCT superimposition. Secondary outcomes consisted of surgical time and soft tissue dehiscence recorded during follow-up visits.
5. Main Findings
After 12 months of follow-up, both manufacturing approaches demonstrated comparable clinical performance. Only one implant failure occurred in the milling group, whereas all implants manufactured through 3D printing remained functional throughout the observation period. However, this difference was not statistically significant.
Radiographic evaluation also revealed similar patterns of peri-implant bone stability. Changes in bone resorption measured between the immediate postoperative CBCT scan and the 12-month examination did not differ significantly between the two groups, suggesting that both manufacturing techniques provided comparable support for long-term implant stability during the study period.
The accuracy of implant placement was assessed by comparing the planned digital implant position with the postoperative CBCT scans. Measurements of both mesiodistal and buccolingual angular deviations showed no statistically significant differences between milled and 3D-printed implants, indicating that both fabrication methods were capable of accurately reproducing the virtual treatment plan.
From a surgical perspective, intervention time was similar in both groups. Likewise, the incidence of soft tissue dehiscence recorded at 3, 6, 9, and 12 months remained comparable, with no statistically significant differences observed throughout follow-up.
Overall, the study demonstrated that CAD/CAM milling and metal 3D printing produced equivalent short-term clinical and radiographic outcomes when manufacturing patient-specific subperiosteal implants for severely atrophic mandibles.
6. Clinical Analysis
One of the main strengths of this randomized clinical trial is that it isolates the influence of the manufacturing process while maintaining the same digital planning protocol and surgical workflow for all participants. This design provides a clearer understanding of whether the fabrication technique itself affects clinical performance.
The findings suggest that successful rehabilitation may depend more on the quality of the complete digital workflow than on whether the implant is produced through subtractive milling or additive manufacturing. Accurate CBCT imaging, meticulous virtual planning, customized implant design, and precise surgical execution appear to play a central role in achieving predictable outcomes.
For clinicians involved in complex implant rehabilitation, these results indicate that both manufacturing technologies can be considered viable options when treating patients with severe mandibular atrophy. Consequently, the decision between milling and 3D printing may reasonably be guided by practical considerations such as laboratory expertise, production capacity, turnaround time, equipment availability, or economic factors rather than by demonstrated differences in short-term clinical effectiveness.
Nevertheless, the findings should not be overinterpreted. The investigation included only 20 patients, limiting the statistical power to detect subtle differences between the two manufacturing techniques. In addition, the 12-month follow-up provides only short-term evidence and cannot predict long-term biological stability, mechanical durability, or prosthetic performance. The authors also acknowledge that variability in surgical execution, management of patients with bruxism, and the inherent limitations of CBCT measurements may have influenced the reported outcomes.
Consequently, while the study supports the feasibility of both manufacturing methods, larger randomized clinical trials with longer follow-up periods will be necessary before definitive conclusions regarding their comparative long-term performance can be established.
7. Clinical Applications
The findings of this randomized clinical trial suggest that patient-specific subperiosteal implants may represent a valuable treatment option for patients with severe mandibular atrophy who are not ideal candidates for conventional endosseous implant placement because of limited residual bone volume.
The comparable outcomes observed with both CAD/CAM milling and metal 3D printing indicate that either manufacturing technique can be incorporated into a fully digital implant workflow. This may be particularly relevant for clinicians using advanced digital treatment planning, guided surgery, and customized implant design in complex oral rehabilitation cases.
The study is especially applicable to situations where extensive bone augmentation procedures may be undesirable or impractical. By relying on individualized implant design rather than conventional implant placement within the residual alveolar bone, patient-specific subperiosteal implants may expand treatment possibilities for carefully selected edentulous patients.
However, this investigation does not compare customized subperiosteal implants with conventional endosseous implants, bone grafting procedures, or other reconstructive techniques. Therefore, the results should not be interpreted as evidence of superiority over established treatment options.
8. Level of Evidence, Study Limitations, and Transparency
This publication represents a randomized clinical trial, providing a higher level of evidence than the case reports and retrospective case series that currently dominate the literature on customized subperiosteal implants. The study followed a randomized parallel-group design and was reported according to CONSORT recommendations.
Despite these methodological strengths, several limitations should be considered. The study included only 20 participants, reducing its statistical power and increasing the possibility of failing to detect small differences between the two manufacturing methods. Furthermore, the 12-month follow-up limits conclusions regarding long-term implant survival, biological stability, prosthetic complications, and mechanical durability.
The authors also acknowledge that variability in surgical procedures, differences in bruxism management, and the intrinsic limitations of CBCT-based measurements may have influenced some of the reported outcomes.
Regarding transparency, the investigators reported no financial support, no conflicts of interest, and obtained approval from the institutional ethics committee. The study protocol was also registered with the Open Science Framework, supporting methodological transparency.
9. Key Study Highlights
- Study design: Randomized parallel-group clinical trial.
- Level of evidence: Randomized clinical trial.
- Study population: Patients with severely atrophic edentulous mandibles requiring implant-supported rehabilitation.
- Number of patients: 20 (10 per treatment group).
- Number of implants: 20 patient-specific subperiosteal implants.
- Follow-up period: 12 months.
- Intervention: CAD/CAM-milled versus metal 3D-printed customized titanium subperiosteal implants.
- Primary outcomes: Implant survival, peri-implant bone resorption, and implant placement accuracy.
- Secondary outcomes: Surgical duration and soft tissue dehiscence.
- Main finding: No statistically significant differences were observed between milling and 3D printing regarding implant survival, radiographic bone stability, placement accuracy, surgical time, or soft tissue complications during the first postoperative year.
- Scientific conclusion: Both manufacturing techniques produced comparable short-term clinical and radiographic outcomes and appear suitable for fabricating patient-specific subperiosteal implants in cases of severe mandibular atrophy.
- Main limitations: Small sample size, one-year follow-up, and the need for larger studies with extended observation periods before broader clinical conclusions can be drawn.
10. Scientific Impact
This randomized clinical trial contributes meaningful comparative evidence to the growing body of literature on patient-specific subperiosteal implants for the rehabilitation of severely atrophic mandibles. While customized titanium subperiosteal implants have experienced renewed interest with the development of digital workflows, most published evidence has consisted of retrospective studies or case series. By directly comparing CAD/CAM milling and metal 3D printing within a randomized design, this study strengthens the current evidence base supporting digitally manufactured customized implants.
An important contribution of this research is the observation that the manufacturing technique itself did not significantly influence short-term clinical or radiographic outcomes. Implant survival, peri-implant bone stability, surgical accuracy, operative time, and soft tissue healing were comparable between both fabrication methods throughout the first postoperative year. These findings reinforce the concept that the success of customized subperiosteal implants may depend more on accurate digital planning, patient-specific design, and precise surgical execution than on the manufacturing process alone.
From a broader scientific perspective, the study also supports the continued integration of digital workflows, including CBCT imaging, virtual treatment planning, CAD/CAM design, and guided surgery, into the management of complex implant rehabilitation cases. Rather than promoting one manufacturing technology over another, the results suggest that both subtractive and additive manufacturing can reliably produce clinically effective customized titanium implants when incorporated into a well-controlled digital protocol.
Nevertheless, the authors appropriately emphasize that the current evidence remains preliminary. The relatively small sample size and limited follow-up prevent definitive conclusions regarding long-term implant survival, biological complications, prosthetic maintenance, and mechanical performance. Future multicenter randomized clinical trials with larger cohorts and extended observation periods will be essential to validate these findings and further define the role of patient-specific subperiosteal implants in contemporary implant dentistry.
11. Editorial Conclusion
This randomized clinical trial provides encouraging evidence that CAD/CAM-milled and 3D-printed patient-specific subperiosteal implants achieve comparable short-term clinical and radiographic outcomes when rehabilitating severely atrophic mandibular ridges. Within the limitations of the study, neither manufacturing technique demonstrated a measurable clinical advantage during the first year of follow-up.
For clinicians involved in advanced implant rehabilitation, these findings support the flexibility of selecting either manufacturing approach according to laboratory capabilities, production logistics, and clinical workflow rather than expecting differences in short-term treatment outcomes. However, the limited sample size and one-year follow-up warrant cautious interpretation, and longer-term investigations remain necessary before these results can be generalized to routine clinical practice.
